These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19041718)

  • 1. Biosimulation of drug metabolism--a yeast based model.
    Pieper I; Wechler K; Katzberg M; Brusch L; Sørensen PG; Mensonides F; Bertau M
    Eur J Pharm Sci; 2009 Jan; 36(1):157-70. PubMed ID: 19041718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the effect of variable enzyme concentrations in a kinetic model of yeast glycolysis.
    Bruck J; Liebermeister W; Klipp E
    Genome Inform; 2008; 20():1-14. PubMed ID: 19425118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model evaluation for glycolytic oscillations in yeast biotransformations of xenobiotics.
    Brusch L; Cuniberti G; Bertau M
    Biophys Chem; 2004 Jun; 109(3):413-26. PubMed ID: 15110938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple gene-mediated NAD(P)H-dependent aldehyde reduction is a mechanism of in situ detoxification of furfural and 5-hydroxymethylfurfural by Saccharomyces cerevisiae.
    Liu ZL; Moon J; Andersh BJ; Slininger PJ; Weber S
    Appl Microbiol Biotechnol; 2008 Dec; 81(4):743-53. PubMed ID: 18810428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic pathways reconstruction by frequency and amplitude response to forced glycolytic oscillations in yeast.
    Zimmerman WB
    Biotechnol Bioeng; 2005 Oct; 92(1):91-116. PubMed ID: 16003780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrient interaction with drugs and other xenobiotics.
    Hayes JR; Borzelleca JF
    J Am Diet Assoc; 1985 Mar; 85(3):335-9. PubMed ID: 3973324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanisms of glycolytic oscillations in yeast.
    Madsen MF; Danø S; Sørensen PG
    FEBS J; 2005 Jun; 272(11):2648-60. PubMed ID: 15943800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural abundance hydrogen isotope affiliation between the reactants and the products in glucose fermentation with yeast.
    Pionnier S; Robins RJ; Zhang BL
    J Agric Food Chem; 2003 Mar; 51(7):2076-82. PubMed ID: 12643676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regioselectivity prediction of CYP1A2-mediated phase I metabolism.
    Jung J; Kim ND; Kim SY; Choi I; Cho KH; Oh WS; Kim DN; No KT
    J Chem Inf Model; 2008 May; 48(5):1074-80. PubMed ID: 18412330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservation of glycolytic oscillations in Saccharomyces cerevisiae and human pancreatic beta-cells: a study of metabolic robustness.
    Silva AS; Yunes JA
    Genet Mol Res; 2006 Aug; 5(3):525-35. PubMed ID: 17117368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics: current state and evolving methodologies and tools.
    Oldiges M; Lütz S; Pflug S; Schroer K; Stein N; Wiendahl C
    Appl Microbiol Biotechnol; 2007 Sep; 76(3):495-511. PubMed ID: 17665194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained glycolytic oscillations--no need for cyanide.
    Poulsen AK; Lauritsen FR; Olsen LF
    FEMS Microbiol Lett; 2004 Jul; 236(2):261-6. PubMed ID: 15251206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drugs and the organism--introduction to pharmacokinetics and biotransformation].
    Pfeifer S; Borchert HH
    Pharmazie; 1978; 33(2-3):128-74. PubMed ID: 674304
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzymology in vivo using NMR and molecular genetics.
    Brindle KM; Fulton AM; Williams SP
    J Mol Recognit; 1993 Dec; 6(4):159-65. PubMed ID: 7917411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state and dynamic flux balance analysis of ethanol production by Saccharomyces cerevisiae.
    Hjersted JL; Henson MA
    IET Syst Biol; 2009 May; 3(3):167-79. PubMed ID: 19449977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hybrid model of anaerobic E. coli GJT001: combination of elementary flux modes and cybernetic variables.
    Kim JI; Varner JD; Ramkrishna D
    Biotechnol Prog; 2008; 24(5):993-1006. PubMed ID: 19194908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolism of drugs. I. Basic metabolic reactions].
    Dyderski S; Grzymisławski M
    Pol Merkur Lekarski; 2005 Apr; 18(106):446-52. PubMed ID: 16161932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cunninghamella--a microbial model for drug metabolism studies--a review.
    Asha S; Vidyavathi M
    Biotechnol Adv; 2009; 27(1):16-29. PubMed ID: 18775773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gastrointestinal microbiota as a site for the biotransformation of drugs.
    Sousa T; Paterson R; Moore V; Carlsson A; Abrahamsson B; Basit AW
    Int J Pharm; 2008 Nov; 363(1-2):1-25. PubMed ID: 18682282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of a biochemical model with preservation of its basic dynamic properties.
    Danø S; Madsen MF; Schmidt H; Cedersund G
    FEBS J; 2006 Nov; 273(21):4862-77. PubMed ID: 17010168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.